We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GTHP market cap is 6.24M. The company's latest EPS is USD -0.0469 and P/E is -1.71.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 36k | 143k | 81k | 13k | 98k |
| Operating Income | -937k | -1.05M | -2.36M | -3.33M | -3.46M |
| Net Income | -1.92M | -401k | -2.43M | -4.97M | -3.66M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.18M | 1.35M | 2.04M | 3.37M | 1.67M |
| Total Liabilities | 18.12M | 12.21M | 7.49M | 6.25M | 5.48M |
| Total Equity | -16.94M | -10.86M | -5.45M | -2.88M | -3.81M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -806k | -1.88M | -1.59M | -1.48M | -1.75M |
| Investing | N/A | -1,000 | -14k | -31k | N/A |
| Financing | 1.71M | 1.16M | 2.07M | 3.18M | 24k |
| Market Cap | 6.24M |
| Price to Earnings Ratio | -1.71 |
| Price to Sales Ratio | 61.54 |
| Price to Cash Ratio | 10.53 |
| Price to Book Ratio | -1.64 |
| Dividend Yield | - |
| Shares Outstanding | 77.97M |
| Average Volume (1 week) | 21.89k |
| Average Volume (1 Month) | 7k |
| 52 Week Change | -27.93% |
| 52 Week High | 0.23 |
| 52 Week Low | 0.064 |
| Spread (Intraday) | 0.01 (11.88%) |
| Company Name | Guided Therapeutics Inc (QB) |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.guidedinc.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
